BRKRBruker
About Bruker
Bruker (NASDAQ:BRKR) specializes in the development, manufacture, and distribution of high-performance scientific instruments and analytical and diagnostic solutions. Its wide product portfolio serves a broad range of customers within the pharmaceutical, biotechnology, clinical, and industrial sectors, among others, enhancing productivity in the life science research and industrial markets. Bruker's commitment to innovation drives its efforts to advance health and safety by providing tools for biotherapeutic and pharmaceutical drug development, as well as advanced materials research. The company's projects often aim at developing new applications and technologies to meet the evolving needs of its global customer base, reinforcing its objectives to improve human health, support environmental sustainability, and contribute to the advancement of scientific research.
What is BRKR known for?
Snapshot
Public US
Ownership
1960
Year founded
4566
Employees
Billerica, United States
Head office
1 of 5
US Rank
Unknown
Sector
N/A
Sector rank
Loading Map...
Operations
All Locations
United States
Produtos e/ou serviços de Bruker
- Magnetic Resonance instruments, including NMR, preclinical MRI, and EPR systems for advanced research in life science and materials science.
- Mass Spectrometry and Separations tools, offering solutions for proteomics, metabolomics, and applied markets.
- X-ray analysis systems, providing innovative solutions for materials research, structural and elemental analysis.
- Microscopy instruments, including atomic force microscopy (AFM) and optical and stylus profilers for nanoscale surface and material characterization.
- Infrared and Raman spectrometers, supporting a wide range of applications in chemical, pharmaceutical, and material analysis.
- Bruker Nano Surfaces Division, offering advanced tools for surface measurement and analysis across a variety of research and industrial applications.
equipe executiva do Bruker
- Dr. Frank H. Laukien Ph.D.Chairman, CEO & President
- Mr. Gerald N. Herman CPAExecutive VP & CFO
- Dr. Mark R. Munch Ph.D.Corporate Executive VP and President of Bruker Nano Group & Corporate
- Mr. Juergen SregaPresident of Bruker CALID Group & Bruker Daltonics Division
- Dr. Falko Busse Ph.D.President of Bruker BioSpin Group
- Mr. Thomas BuresChief Accounting Officer
- Mr. J. Brent Alldredge J.D.Senior VP, General Counsel, Secretary & Global Head of Compliance
- Dr. Burkhard Prause Ph.D.President and CEO of Bruker Energy & Supercon Technologies, Inc.